AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Revenue

AbCellera Biologics had revenue of $35.79M in the twelve months ending March 31, 2024, down -80.23% year-over-year. Revenue in the quarter ending March 31, 2024 was $9.95M, a -18.36% decrease year-over-year. In the year 2023, AbCellera Biologics had annual revenue of $38.03M, a decrease of -92.17%.

• Revenue (ttm): $35.79M
• Revenue Growth: -80.23%
• P/S Ratio: 29.95
• Revenue / Employee: $61,072
• Employees: 586
• Market Cap: 1.07B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	38.03M	-447.40M	-92.17%
Dec 31, 2022	485.42M	110.22M	29.38%
Dec 31, 2021	375.20M	142.05M	60.92%
Dec 31, 2020	233.16M	221.54M	1,907.88%
Dec 31, 2019	11.61M	2.78M	31.49%
Dec 31, 2018	8.83M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.